Key result
Metabolic dysfunction syndrome criteria linked to ~35% higher CVD risk with greater sensitivity than MetS.
Why the study?
To help reduce CVD incidence, this study developed and evaluated metabolic dysfunction syndrome (MDS) criteria as an alternative framework to classical metabolic syndrome (cMS) for CVD risk prediction.
Does the modified metabolic dysfunction syndrome (MDS) criteria improve the prediction of incident cardiovascular disease risk compared to classical metabolic syndrome (cMS) criteria in the UK Biobank and Chinese cohorts?
Cohort
Yes
Does the modified metabolic dysfunction syndrome (MDS) criteria improve the prediction of incident cardiovascular disease risk compared to classical metabolic syndrome (cMS) criteria in the UK Biobank and Chinese cohorts?
A newly proposed metabolic dysfunction syndrome (MDS) framework offers higher sensitivity (84.2%–91.8%) than classical metabolic syndrome criteria for identifying individuals at elevated 10-year risk of incident cardiovascular disease, though with lower specificity.
Answers are grounded in this paper and cite their sources.
Modified criteria may enhance CVD screening sensitivity in UK/Chinese adults; hypothesis-generating and should not yet change practice.
Objective To reduce cardiovascular disease (CVD) incidence, we developed and evaluated criteria for metabolic dysfunction syndrome (MDS) as an alternative framework to classical metabolic syndrome (cMS), assessed MDS components and combinations for CVD risk prediction in the UK Biobank (UKB) cohort, and evaluated these criteria across three independent Chinese cohorts. Methods Cox regression, receiver operating characteristic (ROC) curves, and restricted cubic spline models were used to assess the associations between obesity indicators, MDS components, and CVD in the UKB cohort, adjusting for confounders. The diagnostic performance of MDS vs. cMS for CVD was compared via ROC analysis, with external evaluation performed in three independent Chinese cohorts: CHARLS served as the primary external evaluation cohort, and WCNPCS and Luzhou cohorts provided supportive external evaluation. Results In the UKB cohort, isolated hypertension (iHT), isolated central adiposity (iCA), and several component combinations (DM + Pre-HT/MASLD, Pre-HT+LHDL-C/MASLD, high-risk MASLD+LHDL-C/HTG, and DM+LHDL-C + HTG) significantly increased CVD incidence (HR = 1.08–5.78; p < 0.05). Cox analysis revealed that both MDS and cMS increased subsequent CVD risk in the UKB cohort (HR = 1.35–1.82), with a directionally consistent trend across the Chinese cohorts. MDS showed a sensitivity of 84.2%–91.8%, higher than that of cMS, although at the cost of lower specificity, and was readily identifiable using simple, low-cost measurements. Isolated diabetes (iDM), a small subgroup with no other metabolic abnormalities, showed no significant CVD association in this subgroup. Conclusions Based on 10-year UKB follow-up, the MDS criteria demonstrated higher sensitivity but lower specificity than cMS for identifying individuals at elevated CVD risk, and were supported by primary external validation in CHARLS and supportive external evaluation in the WCNPCS and Luzhou cohorts. These findings should be regarded as preliminary and hypothesis-generating; further independent, prospective validation is required before clinical implementation. Isolated hypertension and central adiposity emerged as the strongest single predictors, whereas isolated diabetes showed no significant association in its metabolically-uncomplicated subgroup and should not be generalized to diabetes overall.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) conducted a cohort in Metabolic dysfunction syndrome and cardiovascular disease risk. Metabolic dysfunction syndrome (MDS) criteria and components vs. Classical metabolic syndrome (cMS) criteria was evaluated on Incident cardiovascular disease (CVD) (HR 1.35-1.82, p=<0.05). Metabolic dysfunction syndrome criteria predicted incident CVD with higher sensitivity but lower specificity than classical metabolic syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: